|
金斯瑞生物科技股份有限公司, 01548.HK - 財務比率 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
變現能力分析 |
流動比率(倍) |
4.76 |
3.23 |
3.97 |
3.03 |
2.47 |
4.43 |
1.46 |
4.18 |
4.31 |
1.5 |
1.29 |
0.99 |
速動比率(倍) |
4.65 |
3.12 |
3.86 |
2.93 |
2.39 |
4.35 |
1.43 |
4.07 |
4.24 |
1.44 |
1.24 |
0.95 |
償債能力分析 |
長期債項/股東權益(%) |
25.24 |
30.18 |
14.19 |
0.86 |
1.4 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
總債項/股東權益(%) |
29.98 |
34.62 |
14.96 |
6.1 |
6.3 |
2.19 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
總債項/資本運用(%) |
14.42 |
17.49 |
8.59 |
4.91 |
3.63 |
1.38 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
投資回報分析 |
股東權益回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
4.43 |
11.99 |
14.73 |
11.73 |
10.01 |
11.42 |
20.79 |
資本運用回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
2.78 |
11.28 |
14.01 |
11.58 |
9.77 |
11.12 |
20.25 |
總資產回報率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
2.31 |
5.18 |
11.58 |
9.61 |
6.68 |
7.16 |
12.15 |
盈利能力分析 |
經營利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
9.91 |
25.26 |
28.33 |
26.5 |
11.2 |
12.53 |
20.95 |
稅前利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
9.83 |
25.24 |
28.33 |
26.5 |
11.2 |
12.53 |
20.95 |
邊際利潤率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
9.18 |
17.11 |
22.81 |
20.19 |
8.82 |
9.98 |
17.33 |
營運能力分析 |
存貨周轉率(倍) |
15.74 |
10.44 |
11.05 |
12.31 |
16.58 |
18.59 |
22.19 |
27.08 |
42.82 |
39.39 |
42.81 |
42.6 |
投資收益分析 |
派息比率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
9.87 |
0.0 |
0.0 |
0.0 |
0.0 |
相關統計 |
財政年度周最高價 |
30.0 |
34.45 |
43.4 |
20.1 |
24.45 |
34.0 |
23.5 |
4.21 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度周最低價 |
16.0 |
13.96 |
9.66 |
10.12 |
9.6 |
8.6 |
3.1 |
1.07 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最高市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
367.8 |
197.86 |
34.58 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低市盈率(倍) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
93.03 |
26.1 |
8.79 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最高週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
1.12 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低週息率(%) |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.29 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|